Lymphoma, Mantle-Cell
Showing 1 - 25 of 45
Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)
Not yet recruiting
- Lymphoma, Mantle-Cell
- Zanubrutinib
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Nov 14, 2023
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +4 more
-
Birmingham, United Kingdom
- +5 more
Sep 18, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023
Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)
Not yet recruiting
- Acute Myeloid Leukemia
- Lymphoma, Mantle-Cell
- (no location specified)
Dec 22, 2022
Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,
Recruiting
- Lymphoma, Follicular
- +5 more
- ADI-001
- +2 more
-
Stanford, California
- +6 more
Oct 19, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)
Available
- Leukemia, Lymphocytic, Chronic, B-Cell
- +4 more
-
Stanford, California
- +61 more
Aug 17, 2022
Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)
Not yet recruiting
- Lymphoma, Mantle-Cell
- +7 more
- Zilovertamab
- +2 more
- (no location specified)
Jun 21, 2022
Allogeneic Gamma Delta (?d) CAR T Cells
Enrolling by invitation
- Lymphoma, Follicular
- +5 more
- ADI-001
-
Stanford, California
- +4 more
Jun 7, 2022
Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)
Completed
- Lymphoma, Mantle-Cell
- Recurrent Lymphoma, Mantle-Cell
- ABT-199 and Ibrutinib Combination
-
Duarte, California
- +3 more
May 22, 2022
Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Lymphoma
- +4 more
- IM19 CAR-T cells
- +2 more
- (no location specified)
Nov 30, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Lymphoma, Mantle-Cell Trial in Czechia (Polatuzumab vedotin, Bendamustine Hydrochloride, Rituximab)
Not yet recruiting
- Lymphoma, Mantle-Cell
- Polatuzumab vedotin
- +2 more
-
Brno, Czechia
- +6 more
May 28, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Anyang, Korea, Republic of
- +12 more
Apr 6, 2021
Bortezomib Treatment on Mantle Cell Lymphoma in Chinese
Completed
- Lymphoma, Mantle-Cell
-
Beijing, China
- +8 more
Nov 5, 2020
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Mantle-Cell
-
Ahmedabad, India
- +7 more
Aug 5, 2020
Kinetics of Lymphoid Cells in Monoclonal B-cell Lymphocytosis,
Completed
- Lymphoma, Mantle-cell
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 13, 2020
Lymphoma, Mantle-Cell Trial in Stanford (biological, procedure, drug)
Completed
- Lymphoma, Mantle-Cell
- CpG-MCL vaccine
- +7 more
-
Stanford, CaliforniaStanford University Medical Center
Jan 8, 2020
Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)
Completed
- Lymphoma, Mantle-Cell
- Tositumomab and Iodine I 131 Tositumomab followed by CHOP
- (no location specified)
Nov 19, 2019